SCHEMBL4148264

SCHEMBL4148264

CC(=O)C(C)CCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13282236 1.00
SCHEMBL13282367 0.93 GSR (0.46)
SCHEMBL12037633 0.93 GSR (0.46)
SCHEMBL14525102 0.93 GSR (0.46)
SCHEMBL24915285 0.84
SCHEMBL12153331 0.84 CA1 (0.48)
SCHEMBL12153332 0.81 CA1 (0.46)
SCHEMBL12037637 0.80 PAOX (0.48)
SCHEMBL1694022 0.80
SCHEMBL4791093 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114958291-B Single-component high-adhesion room temperature vulcanized organosilicon sealant and preparation method thereof 北京航空材料研究院股份有限公司 2023-07-04 CN disclosed
WO-2023102507-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-06-08 WO disclosed
US-10869863-B2 Multi-arm polymeric targeting anti-cancer conjugate BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (CN) 2020-12-22 US disclosed
US-20160303062-A1 ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE NATIONAL SCIENCE FOUNDATION 2016-10-20 US disclosed
US-9380784-B2 Antimicrobial compositions and methods of use NATIONAL SCIENCE FOUNDATION 2016-07-05 US disclosed
US-20160186273-A1 BACILLUS AMYLOLIQUEFACIENS RTI301 COMPOSITIONS AND METHODS OF USE FOR BENEFITING PLANT GROWTH AND TREATING PLANT DISEASE FMC CORPORATION 2016-06-30 US disclosed
WO-2013016057-A1 POLY(ORNITHINE) HOMOPOLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES MERCK SHARP & DOHME CORP. (US) 2013-01-31 WO disclosed
US-20110165261-A1 ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC (US) 2011-07-07 US disclosed
US-20090170847-A1 Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same YUYU PHARMA, INC. (KR) 2009-07-02 US disclosed
EP-1984370-A1 IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Crystalgenomics, Inc. (KR) 2008-10-29 EP disclosed
WO-2007083978-A1 IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME CRYSTALGENOMICS, INC. (KR) 2007-07-26 WO disclosed